← Back
Data updated: Mar 10, 2026
BPI LABS
Pharmaceuticals
BPI LABS is a specialty pharmaceutical company with 10 FDA-approved products.
2014
Since
10
Drugs
-
Trials
60
Approved (2yr)
Recent Activity
ZOLEDRONIC ACID 2026-02-05
SELENIOUS ACID 2026-02-03
SELENIOUS ACID 2025-12-31
EPINEPHRINE 2025-12-08
TRIMETHOBENZAMIDE HYDROCHLORIDE 2025-10-16
EPINEPHRINE 2025-10-14
NALOXONE HYDROCHLORIDE 2025-08-21
ZOLEDRONIC ACID 2025-08-15
Labeling
NALOXONE HYDROCHLORIDE 2025-08-01
Labeling
ZOLEDRONIC ACID 2025-07-30
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Discontinued (6)
Company Info
- First Approval
- 2014-07-29
- Latest
- 2025-10-16
- Applications
- 10
FDA Sponsor Names
BPI LABSBPI LABS LLC